Cargando…

Phase II Clinical Trial of Combination Therapy with Favipiravir and Methylprednisolone for COVID-19 with Non-Critical Respiratory Failure

INTRODUCTION: The administration of systemic corticosteroids is a key strategy for improving COVID-19 outcomes. However, evidence is lacking on combination therapies of antiviral agents and systemic corticosteroids. The objective of this study was to investigate the efficacy and safety of the combin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shindo, Yuichiro, Kondoh, Yasuhiro, Kada, Akiko, Doi, Yohei, Tomii, Keisuke, Mukae, Hiroshi, Murata, Naohiko, Imai, Ryosuke, Okamoto, Masaki, Yamano, Yasuhiko, Miyazaki, Yasunari, Shinoda, Masahiro, Aso, Hiromichi, Izumi, Shinyu, Ishii, Haruyuki, Ito, Ryota, Saito, Akiko M., Saito, Toshiki I., Hasegawa, Yoshinori
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349598/ https://www.ncbi.nlm.nih.gov/pubmed/34368914 http://dx.doi.org/10.1007/s40121-021-00512-9

Ejemplares similares

Favipiravir/methylprednisolone: Off-label use and lack of efficacy: case report
Publicado: (2022)

Outcome of early-stage combination treatment with favipiravir and methylprednisolone for severe COVID-19 pneumonia: A report of 11 cases
por: Murohashi, Kota, et al.
Publicado: (2020)

Favipiravir/hydroxychloroquine/methylprednisolone: Nephrotoxicity following an off-label use: 2 case reports
Publicado: (2021)

Multicentre, open-label, randomised controlled clinical trial to assess the efficacy and safety of appropriate target values for lipid management in patients who have mild-to-moderate stenotic lesions with high-risk plaques in coronary arteries: study protocol
por: Matsuda, Morihiro, et al.
Publicado: (2019)

Dexamethasone/favipiravir/methylprednisolone: Hyperglycaemia, masking of cytokine storm and off-label use: 2 case reports
Publicado: (2021)

Population pharmacokinetics of favipiravir in patients with COVID‐19
por: Irie, Kei, et al.
Publicado: (2021)

Potential for replacing warfarin with a direct oral anticoagulant for endoscopic mucosal resection in the colorectum: A multicenter, open‐label, randomized controlled trial
por: Yamada, Takuya, et al.
Publicado: (2022)

Pharmacokinetics of Favipiravir in Critically Ill Patients With COVID‐19
por: Irie, Kei, et al.
Publicado: (2020)

Rationale and protocol design of a phase II study of first-line osimertinib treatment for patients with poor performance status and EGFR mutation-positive non-small cell lung cancer (OPEN/TORG2040)
por: Fukui, Tomoya, et al.
Publicado: (2022)

Phase II trial of CH5424802 (alectinib hydrochloride) for recurrent or refractory ALK-positive anaplastic large cell lymphoma: study protocol for a non-randomized non-controlled trial
por: Nagai, Hirokazu, et al.
Publicado: (2017)

Phase I clinical study of brentuximab vedotin (SGN-35) involving children with recurrent or refractory CD30-positive Hodgkin’s lymphoma or systemic anaplastic large cell lymphoma: rationale, design and methods of BV-HLALCL study: study protocol
por: Sekimizu, Masahiro, et al.
Publicado: (2018)

Detailed Analyses of Molecular Interactions between Favipiravir and RNA Viruses In Silico
por: Shirai, Tatsuya, et al.
Publicado: (2022)

Replacement of warfarin with a novel oral anticoagulant in endoscopic mucosal resection: a multicentre, open-label, randomised controlled trial
por: Yamada, Takuya, et al.
Publicado: (2017)

Alternating bortezomib-dexamethasone and lenalidomide-dexamethasone in patients with newly diagnosed multiple myeloma aged over 75 years
por: Yokoyama, Akihiro, et al.
Publicado: (2022)

Effectiveness of Favipiravir on Nonsevere, Early-Stage COVID-19 in Japan: A Large Observational Study Using the COVID-19 Registry Japan
por: Tsuzuki, Shinya, et al.
Publicado: (2022)

HIV infection, and overweight and hypertension: a cross-sectional study of HIV-infected adults in Western Kenya
por: Saito, Akiko, et al.
Publicado: (2020)

Mesalazine-induced lung injury with severe respiratory failure successfully treated with steroids and non-invasive positive pressure ventilation
por: Oi, Hajime, et al.
Publicado: (2020)

Reporting quality of randomized controlled trials in patients with HIV on antiretroviral therapy: a systematic review
por: Nagai, Kaori, et al.
Publicado: (2017)

Outcome of Nivolumab-Induced Vogt–Koyanagi–Harada Disease-Like Uveitis in a Patient Managed without Intravenous Methylprednisolone Therapy
por: Nagai, Ryoji, et al.
Publicado: (2023)

Virological and genomic analysis of SARS-CoV-2 from a favipiravir clinical trial cohort
por: Suzuki, Masahiro, et al.
Publicado: (2021)

Phase II/III study in children and adolescents with newly diagnosed B-cell precursor acute lymphoblastic leukemia: protocol for a nationwide multicenter trial in Japan
por: Koh, Katsuyoshi, et al.
Publicado: (2018)

Weekly nanoparticle albumin-bound paclitaxel and paclitaxel for relapsed small cell lung cancer: A retrospective observational study
por: Oi, Hajime, et al.
Publicado: (2022)

Using the drug repositioning approach to develop a novel therapy, tipepidine hibenzate sustained-release tablet (TS-141), for children and adolescents with attention-deficit/hyperactivity disorder
por: Saito, Takuya, et al.
Publicado: (2020)

Pulse Methylprednisolone Versus Dexamethasone in COVID-19: A Multicenter Cohort Study
por: Watanabe, Atsuyuki, et al.
Publicado: (2023)

Favipiravir for symptomatic COVID-19: A nationwide observational cohort study
por: Doi, Yohei, et al.
Publicado: (2023)

ICU admission and favipiravir
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

A Favipiravir-induced Fever in a Patient with COVID-19
por: Kurita, Takashi, et al.
Publicado: (2020)

An open-label, single-arm study of CRYO2 for tissue removal at the site of central airway obstruction or stenosis: study protocol
por: Saka, Hideo, et al.
Publicado: (2018)

Effect of the 2020 hypersensitivity pneumonitis guideline on the pathologic diagnosis of interstitial pneumonia
por: Ozasa, Mutsumi, et al.
Publicado: (2023)

Acute Gouty Arthritis During Favipiravir Treatment for Coronavirus Disease 2019
por: Hase, Ryota, et al.
Publicado: (2020)

The mechanism of resistance to favipiravir in influenza
por: Goldhill, Daniel H., et al.
Publicado: (2018)

Favipiravir in Therapy of Viral Infections
por: Łagocka, Ryta, et al.
Publicado: (2021)

Favipiravir: Hyperuricaemia: case report
Publicado: (2021)

Free Radical Scavenging Capacities and Alleviating Actions of Polysaccharides Extract of Termitomyces le-testui on Methylprednisolone-Induced Immunodepression in Rats
por: Evans Ngwenah, Foncham, et al.
Publicado: (2021)

Evaluation of minocycline combined with favipiravir therapy in coronavirus disease 2019 patients: A case-series study
por: Itoh, Kazuhiro, et al.
Publicado: (2022)

Anti‐MDA5 antibody‐positive clinically amyopathic dermatomyositis with diffuse alveolar damage diagnosed by transbronchial lung cryobiopsy: A case report
por: Ishihara, Hiroyuki, et al.
Publicado: (2021)

Acute exacerbation of idiopathic pulmonary fibrosis after SARS-CoV-2 vaccination
por: Bando, Tomohiro, et al.
Publicado: (2022)

Two cases of acute respiratory failure following SARS‐CoV‐2 vaccination in post‐COVID‐19 pneumonia
por: Bando, Tomohiro, et al.
Publicado: (2022)

Endoscopic submucosal dissection for adenoma in gastric adenocarcinoma and proximal polyposis of the stomach
por: Saito, Yuri, et al.
Publicado: (2023)

Deep Vein Thrombosis in Severe Motor and Intellectual Disabilities Patients and Its Treatment by Anticoagulants of Warfarin Versus Edoxaban
por: Ohmori, Hiromitsu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_knlj1pfef4eruu3k123aqje2sd